
    
      Primary outcome measures:

        1. Change from screening in corneal confocal microscopic findings at month 12

        2. Change from screening in ocular symptoms upon non-instillation at month 12

        3. Change from screening in ocular signs at month 12

           Safety and QoL variables:

        4. Descriptive statistics, identification of change(s) from screening
    
  